RE:RE:RE:RE:RE:RE:RE:RE:Fair Market ValueGood Morning inthno. It was my fault. I was almost certain AN did not have Japan (thank goodness) and should have confirmed that myself, but was looking at MM at the time. Neither should I have asked the question about CAR T and liquid and solid tumors. A very difficult question to answer, especially on this medium. I do wonder if pela and CAR T fit with MM.
For what it's worth I believe you to be a frustrated long, and that you have the best and most accessible ONC archive. I would be very surprised if MC exercised those options. Frankly I did not expect it; he has shown his colours on many occasions. On the plus side. he seems to have steered ONC to some good results, and is still able to attract bright people.
However, raising funds from Anson raises flags. I do not get it. I certainly do not think the braintrust at ONC did us any favours. The smart money here has traded the stock over the years; I would have also, but I am no good at it.
Anyway ONC (owing to little cash) seems to be involved in too many projects. I may be wrong; perhaps it is a necessary strategy. Shareholders should remember a lot of the research funding is coming from other than our own coffers.
I do think the runway is very short, and will be disappointed if we do not have material change very soon. Read that as substantial funding or a buyout. I am going to hold.
Have a great holiday.